Back
Compare AU
Compare GAME vs. CURE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares Video Games and Esports ETF (GAME) and the Global X S&P Biotech ETF (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
GAME | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 117 | 72 |
Median incremental investment | $993.50 | $683.16 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,092.96 | $2,356.52 |
Average age group | > 35 | > 35 |
Key Summary
GAME | CURE | |
|---|---|---|
Strategy | GAME.AX was created on 2022-02-07 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. GAME.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to a portfolio of leading global video gaming and esports companies. | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 47.2m in AUM and 148 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. |
Top 3 holdings | UNITY SOFTWARE INC (11.20 %) NETEASE INC (8.43 %) BANDAI NAMCO HOLDINGS INC (8.00 %) | Apogee Therapeutics Inc (1.57 %) Twist Bioscience Corp (1.56 %) Praxis Precision Medicines Inc Ordinary Shares (1.49 %) |
Top 3 industries | Other (60.29 %) Communication Services (26.03 %) Information Technology (13.68 %) | Health Care (100.00 %) Other (10.24 %) |
Top 3 countries | Japan (34.71 %) United States (33.19 %) China (20.37 %) | United States (96.62 %) United Kingdom of Great Britain and Northern Ireland (1.35 %) Switzerland (1.13 %) |
Management fee | 0.57 % | 0.45 % |
Key Summary
GAME | CURE | |
|---|---|---|
Issuer | BetaShares | Global X |
Tracking index | Nasdaq CTA Global Video Games & Esports Index - AUD - Benchmark TR Net | S&P Biotechnology Select Industry |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.45 % |
Price | $15.18 | $74.81 |
Size | $28.496 million | $47.195 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 0.89 % | 0.03 % |
Market | ASX | ASX |
First listed date | 08/02/2022 | 12/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
GAME | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 117 | 72 |
Median incremental investment | $993.50 | $683.16 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,092.96 | $2,356.52 |
Average age group | > 35 | > 35 |
Pros and Cons
GAME | CURE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
GAME | CURE |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |